COVID-19 antigen test approved by France and Thailand, INNOVITA contributes China’s Strength on fighting the epidemic globally

In early August, INNOVITA 2019-nCoV antigen test was approved by the French National Drug and Health Products Safety Agency (ANSM) and Thailand Food and Drug Administration (Thai FDA), by then, INNOVITA Covid-19 test has been registered in nearly 30 countries.

These countries include China, the United States, Brazil, France, Italy, Russia, Spain, Portugal, the Netherlands, Hungary, Austria, Sweden, Singapore, the Philippines, Malaysia, Thailand, Argentina, Ecuador, Colombia, Peru, Chile, Mexico, etc. At present, INNOVITA is also applying for CE certification and registration of US FDA COVID-19 antigen test, to accelerate the expansion of overseas registration scale of COVID-19 testing kits.
After exported to the above countries, INNOVITA provides accurate, rapid and large-scale investigation of COVID-19 infections has played an important role in the fight against COVID-19 in each country.

After the outbreak of COVID-19 in 2020, INNOVITA responded quickly and dispatched elite R&D personnel to conduct scientific research day and night, and successfully developed a novel coronavirus (2019-nCoV) antibody test kit and was approved by NMPA. INNOVITA was among the first companies in China to obtain the registration certificate of COVID-19 antibody test kit. The products now are well sold both domestic and abroad, contributing a lot on fighting the epidemic. In September 2020, INNOVITA was awarded “National Advanced Collective” in National commendation congress for combating COVID-19 pandemic. On January 26 2021, the Ministry of Science and Technology also sent a letter of thanks to INNOVITA for the support in the emergency research project to fight the epidemic。
In the future, INNOVITA will continue to take advantage of its technical merit and good quality, explore global market and contribute China Strength on fighting the epidemic globally!

Post time: Oct-18-2021